THE INNOVATIVE MEDICINES INITIATIVE

The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.

IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.

EU Logoefpia Logo

 

IMI LAUNCHES EBOLA+ PROGRAMME

IMI has launched an ambitious programme to accelerate the development of vaccines and treatments against Ebola and related diseases. The first Call under the Ebola+ programme has a total budget of €280m.

more

ONGOING PROJECTS

  • A life-saving technology

    IMI project SUMMIT has developed an ultrasound device to identify patients at imminent risk of a heart attack or stroke

    ... more
  • Action on autism

    Watch a video on how EU-AIMS is developing tools to boost our understanding of autism, paving the way for new treatments

    ... more
  • Get on-course!

    With over 5 000 courses, on-course, run by the EMTRAIN project, is Europe's most comprehensive biomedical R&D postgrad course portal

    ... more
  • Innovation in action

    IMI's 46 projects have a combined budget of €1.6 billion and are tackling some of the toughest challenges in drug development.

    ... more
  • Patient power!

    EUPATI is developing educational resources that will empower patients to engage more effectively in the drug research and development process

    ... more
  • Schizophrenia breakthrough

    NEWMEDS project research published in Nature reveals that genetic variants linked with schizophrenia have an impact in healthy carriers

    ... more
All projects

FUTURE CALLS

The following topics are under consideration for inclusion in future Calls:

 - Remote assessment
 - Type 2 diabetes
 - Neuropsychiatry
 - Vaccine manufacture
 - Pertussis vaccines
 - Patient engagement
 - Adaptive pathways

IMI NEWSFLASH IMI News Flash

 
  • 21/11/2014 : RT @DIRECTdiabetes: Fantastic open house at Lund diabetes centre. 93 DIRECT participants came to talk about #diabetes #research and have up…
  • 20/11/2014 : RT @eupatients: European Pharma - very active on Twitter! http://t.co/XvaT0vlsop
  • 19/11/2014 : RT @DIRECTdiabetes: Our researchers at Lund are getting ready to welcome participants to open house tomorrow! Great chance to hear more abo…

Follow us on Twitter